Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

13/08/2020 07:00

Aug 13 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               37.90               28.41           150.00    
                   (+33.4 pct)         (+11.4 pct)      (+35.9 pct) 
  Operating            4.57                5.21            14.30    
                   (-12.3 pct)         (+48.8 pct)      (-11.4 pct) 
  Recurring            4.78                5.28            14.80    
                   (-9.6 pct)          (+9.9 pct)       (-29.5 pct) 
  Net                  3.34                3.76            10.40    
                   (-11.4 pct)         (+5.6 pct)       (-28.3 pct) 
  EPS               67.77 yen           76.51 yen       211.34 yen  
  EPS Diluted       62.66 yen           70.77 yen                   
  Ann Div                               44.00 yen        44.00 yen  
  -Q2 div                               22.00 yen        22.00 yen  
  -Q4 div                               22.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T